Clinical Trial

Treatment Preventive for Pre-eclampsia by Acetylsalicylic Acid in Women Who Underwent Frozen Embryo Transfer

Study acronym: TePPAFET
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated February 18, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Title: A prospective multicentric interventional randomized controlled trial to assess the effect of low dose acetylsalicylic acid as a preventive treatment of pre-eclampsia in pregnant women who underwent frozen embryo transfer
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-07-13; most recent amendment 2025-02-14.
Status change: Not Yet Recruiting → Recruiting 2024-08-29
Trial Details
NCT Number NCT05460416
Lead Sponsor Centre Hospitalier Universitaire de Liege
Conditions Embryo Transfer, Hypertension, Pregnancy Induced
Enrollment 276 participants
Start Date 2022-10-25
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-18